SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-17
DOI
10.1038/s41598-019-46594-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A lipid-free and insulin-supplemented medium supports De Novo fatty acid synthesis gene activation in melanoma cells
- (2019) Su Wu et al. PLoS One
- A Convergence-Based Framework for Cancer Drug Resistance
- (2018) David J. Konieczkowski et al. CANCER CELL
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Harnessing Tumor Evolution to Circumvent Resistance
- (2018) Katherine L. Pogrebniak et al. TRENDS IN GENETICS
- Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
- (2018) Ali Talebi et al. Nature Communications
- mTORC1 Phosphorylates Acetyltransferase p300 to Regulate Autophagy and Lipogenesis
- (2017) Wei Wan et al. MOLECULAR CELL
- Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
- (2017) Xiangjun Kong et al. NATURE
- Toil enables reproducible, open source, big biomedical data analyses
- (2017) John Vivian et al. NATURE BIOTECHNOLOGY
- Targeted therapy: An elusive cancer target
- (2016) Carolyn Brown NATURE
- Proteogenomics connects somatic mutations to signalling in breast cancer
- (2016) Philipp Mertins et al. NATURE
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks
- (2016) Angelo Fortunato et al. Cold Spring Harbor Perspectives in Medicine
- ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization
- (2015) Guangchuang Yu et al. BIOINFORMATICS
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Molecular Pathways: Fatty Acid Synthase
- (2015) S. F. Jones et al. CLINICAL CANCER RESEARCH
- Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target
- (2015) Christina A. von Roemeling et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression
- (2015) Laurent Vergnes et al. JOURNAL OF LIPID RESEARCH
- Transcriptional regulation of hepatic lipogenesis
- (2015) Yuhui Wang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
- (2015) Sarah J. Welsh et al. Therapeutic Advances in Medical Oncology
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
- (2014) Lisa M. Sedger et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Evolutionary mechanism unifies the hallmarks of cancer
- (2014) Steven D. Horne et al. INTERNATIONAL JOURNAL OF CANCER
- Systemic treatment for BRAF-mutant melanoma: where do we go next?
- (2014) Alexander M Menzies et al. LANCET ONCOLOGY
- A human fatty acid synthase inhibitor binds β-ketoacyl reductase in the keto-substrate site
- (2014) Mary Ann Hardwicke et al. Nature Chemical Biology
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids
- (2013) Sharon M. Louie et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
- (2013) Francisca Vazquez et al. CANCER CELL
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
- (2013) Rizwan Haq et al. CANCER CELL
- Cellular Fatty Acid Metabolism and Cancer
- (2013) Erin Currie et al. Cell Metabolism
- Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges
- (2013) Rodrigo Dienstmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutaneous melanoma
- (2013) Alexander MM Eggermont et al. LANCET
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36∶1) with High Stearoyl-CoA Desaturase-1 Expression
- (2013) Yoshimi Ide et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
- (2013) E. J. Morris et al. Cancer Discovery
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- The Genetic Basis for Cancer Treatment Decisions
- (2012) Janet E. Dancey et al. CELL
- Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma
- (2012) Vipin Yadav et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans
- (2012) Karen Adelman et al. NATURE REVIEWS GENETICS
- Stearoyl CoA Desaturase 1: Role in Cellular Inflammation and Stress
- (2012) Xueqing Liu et al. Advances in Nutrition
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils
- (2011) Davide Torti et al. EMBO Molecular Medicine
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- SREBPs: metabolic integrators in physiology and metabolism
- (2011) Tae-Il Jeon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Potential Relevance of Bell-Shaped and U-Shaped Dose-Responses for the Therapeutic Targeting of Angiogenesis in Cancer
- (2010) Andrew R. Reynolds Dose-Response
- Polyunsaturated Fatty Acids Selectively Suppress Sterol Regulatory Element-binding Protein-1 through Proteolytic Processing and Autoloop Regulatory Circuit
- (2010) Yoshinori Takeuchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism
- (2010) Bhaskar Ponugoti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical Implications of the Cancer Genome
- (2010) Laura E. MacConaill et al. JOURNAL OF CLINICAL ONCOLOGY
- The Akt–SREBP nexus: cell signaling meets lipid metabolism
- (2010) James R. Krycer et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Mutational Heterogeneity in Human Cancers: Origin and Consequences
- (2009) Jesse J. Salk et al. Annual Review of Pathology-Mechanisms of Disease
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- GAGE: generally applicable gene set enrichment for pathway analysis
- (2009) Weijun Luo et al. BMC BIOINFORMATICS
- De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
- (2009) T Mashima et al. BRITISH JOURNAL OF CANCER
- Differential chromatin marking of introns and expressed exons by H3K36me3
- (2009) Paulina Kolasinska-Zwierz et al. NATURE GENETICS
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams
- (2008) Tim Hulsen et al. BMC GENOMICS
- Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL
- (2008) Michael S. Brown et al. JOURNAL OF LIPID RESEARCH
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Genome-Wide Occupancy of SREBP1 and Its Partners NFY and SP1 Reveals Novel Functional Roles and Combinatorial Regulation of Distinct Classes of Genes
- (2008) Brian D. Reed et al. PLoS Genetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More